Bo Liang is the Vice President and the Co-founder of Zhimeng Biopharma. Dr. Liang is an expert in synthetic chemistry and drug discovery. Prior to starting Zhimeng Biopharma, Dr. Liang was the Head of chemistry in Zhendong Pharmaceuticals' R&D Center in Beijing, responsible for the research and development of small molecule innovative drugs.
Before joining Zhendong, Dr. Liang was the Director of synthetic chemistry at the Shanghai R&D Center of Simcere, Inc., leading the chemistry efforts in research and development of innovative medicines to treat CNS and oncology diseases.
Dr. Liang was a Group Leader of chemistry at BioDuro, Beijing, China, responsible for the medicinal chemistry of the company's cooperative R&D projects.
Dr. Liang obtained his Ph.D. in chemistry at Peking University (Beijing, China) and received his post-doctoral training at Boston University (USA).